Membrane bioreactor for pharmaceutically active compounds removal: Effects of carbamazepine on mixed microbial communities implied in the treatment

被引:26
作者
Aubenneau, Michael [1 ]
Tahar, Alexandre [1 ]
Casellas, Claude [2 ]
Wisniewski, Christelle [1 ]
机构
[1] Univ Montpellier 1, UMR CIRAD Genie Proc Eau & Bioprod GPEB 016, UFR Sci Pharmaceut & Biol, F-34093 Montpellier 5, France
[2] Univ Montpellier 1, UMR Hydrosci 5569, Dept Sci Environm & Sante Publ, UFR Sci Pharmaceut & Biol, F-34093 Montpellier 5, France
关键词
Membrane bioreactor; Carbamazepine; Micropollutants; Respirometry; Activated sludge; WASTE-WATER TREATMENT; SEWAGE-TREATMENT PLANTS; AQUATIC ENVIRONMENT; SLUDGE; DRUGS; FATE; TRIMETHOPRIM; ELIMINATION; RESIDUES; SYSTEM;
D O I
10.1016/j.procbio.2010.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this work consists in evaluating the influence of carmabazepine (CBZ) (i) on the endogenous and exogenous respirations, in batch reactors, of bacterial populations taken from a conventional activated sludge process (CAS) and a pilot-scale membrane bioreactor (MBR) and (ii) on COD removal, sludge production and oxygen requirement of a lab-sale MBR system. In batch experiments, the increase in endogenous oxygen needs suggests an increase in maintenance requirements, essentially to manage the chemical stress induced by the CBZ presence. The decrease of exogenous oxygen needs seems to suggest a change in the metabolic pathways of the substrate or a change in the active bacterial species. However, in spite of these momentary changes, no inhibition is observed in the presence of CBZ in the test tank. This result is confirmed by the MBR experiment where no significant difference COD removal, sludge production and oxygen requirement is observed, with and without CBZ. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1826 / 1831
页数:6
相关论文
共 27 条
[1]   Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment [J].
Andreozzi, R ;
Marotta, R ;
Paxeus, N .
CHEMOSPHERE, 2003, 50 (10) :1319-1330
[2]  
[Anonymous], 1994, STANDARD METHODS EXA, V16th
[3]   The immunochemical detection of stress proteins in activated sludge exposed to toxic chemicals [J].
Bott, CB ;
Love, NG .
WATER RESEARCH, 2001, 35 (01) :91-100
[4]   Removal of pharmaceuticals in sewage treatment plants in Italy [J].
Castiglioni, S ;
Bagnati, R ;
Fanelli, R ;
Pomati, F ;
Calamari, D ;
Zuccato, E .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (01) :357-363
[5]   Pharmaceuticals and personal care products in the environment: Agents of subtle change? [J].
Daughton, CG ;
Ternes, TA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 :907-938
[6]   Effect of cytostatic drugs on microbial behaviour in membrane bioreactor system [J].
Delgado, Luis F. ;
Schetrite, Sylvie ;
Gonzalez, Carlos ;
Albasi, Claire .
BIORESOURCE TECHNOLOGY, 2010, 101 (02) :527-536
[7]   Occurrence, fate and effects of pharmaceutical substances in the environment - A review [J].
Halling-Sorensen, B ;
Nielsen, SN ;
Lanzky, PF ;
Ingerslev, F ;
Lutzhoft, HCH ;
Jorgensen, SE .
CHEMOSPHERE, 1998, 36 (02) :357-394
[8]   From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas [J].
Heberer, T ;
Reddersen, K ;
Mechlinski, A .
WATER SCIENCE AND TECHNOLOGY, 2002, 46 (03) :81-88
[9]   The impact of floc size on respiration inhibition by soluble toxicants - a comparative investigation [J].
Henriques, IDS ;
Holbrook, RD ;
Kelly, RT ;
Love, NG .
WATER RESEARCH, 2005, 39 (12) :2559-2568
[10]   Removal of pharmaceuticals and fragrances in biological wastewater treatment [J].
Joss, A ;
Keller, E ;
Alder, AC ;
Göbel, A ;
McArdell, CS ;
Ternes, T ;
Siegrist, H .
WATER RESEARCH, 2005, 39 (14) :3139-3152